Osama Roshdy

692 total citations
24 papers, 448 citations indexed

About

Osama Roshdy is a scholar working on Oncology, Dermatology and Epidemiology. According to data from OpenAlex, Osama Roshdy has authored 24 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Dermatology and 7 papers in Epidemiology. Recurrent topics in Osama Roshdy's work include Nonmelanoma Skin Cancer Studies (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Cutaneous Melanoma Detection and Management (4 papers). Osama Roshdy is often cited by papers focused on Nonmelanoma Skin Cancer Studies (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Cutaneous Melanoma Detection and Management (4 papers). Osama Roshdy collaborates with scholars based in Canada, Egypt and Germany. Osama Roshdy's co-authors include Elena Netchiporouk, Elham Rahme, Feras M. Ghazawi, Ivan V. Litvinov, Denis Sasseville, Steven J. Glassman, Linda Moreau, Andrei Zubarev, Michelle Le and Brett Hughes and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Osama Roshdy

20 papers receiving 435 citations

Peers

Osama Roshdy
Ausilia Maria Manganoni Italy
V. Buffard France
Ariënne M. W. Van Marion Netherlands
Anne-Bénédicte Duval-Modeste France
Matthew Tsang Canada
Silvana Festa Italy
Anna Peroni Italy
Marit Scheistrøen Norway
Nina Booken Germany
Karl Rodins Australia
Ausilia Maria Manganoni Italy
Osama Roshdy
Citations per year, relative to Osama Roshdy Osama Roshdy (= 1×) peers Ausilia Maria Manganoni

Countries citing papers authored by Osama Roshdy

Since Specialization
Citations

This map shows the geographic impact of Osama Roshdy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Osama Roshdy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Osama Roshdy more than expected).

Fields of papers citing papers by Osama Roshdy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Osama Roshdy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Osama Roshdy. The network helps show where Osama Roshdy may publish in the future.

Co-authorship network of co-authors of Osama Roshdy

This figure shows the co-authorship network connecting the top 25 collaborators of Osama Roshdy. A scholar is included among the top collaborators of Osama Roshdy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Osama Roshdy. Osama Roshdy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lefrançois, Philippe, Herbert E. Cohn, Pingxing Xie, et al.. (2025). 63205 The Transcriptional Landscape Analysis of High-Risk Aggressive Basal Cell Carcinoma Identifies Subtype-Specific Biomarkers and Cancer Promotion Pathways. Journal of the American Academy of Dermatology. 93(3). AB326–AB326.
2.
3.
Ibrahim, Mohammad A. A., et al.. (2024). E- Selectin as a Predictor for Overt and Subclinical Cardiovascular Riskin Patients with Juvenile Idiopathic Arthritis. QJM. 117(Supplement_2). 1 indexed citations
4.
Muñoz‐Couselo, Eva, Brett Hughes, Laurent Mortier, et al.. (2024). Pembrolizumab (pembro) for locally advanced (LA) or recurrent/metastatic (R/M) cutaneous squamous cell carcinoma (cSCC): Long-term results of the phase 2 KEYNOTE-629 study.. Journal of Clinical Oncology. 42(16_suppl). 9554–9554. 3 indexed citations
5.
Bratland, Åse, Eva Muñoz‐Couselo, Laurent Mortier, et al.. (2023). Health-Related Quality of Life with Pembrolizumab in Patients with Locally Advanced or Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: KEYNOTE-629. Dermatology and Therapy. 13(12). 3165–3180. 1 indexed citations
6.
Roshdy, Osama, et al.. (2022). Stromal vascular fraction improves the durability of autologous fat temple augmentation—A split-face randomized study using ultrasound biomicroscopy. Journal of Plastic Reconstructive & Aesthetic Surgery. 75(6). 1870–1877. 11 indexed citations
7.
Hughes, Brett, Laurent Mortier, Å. Bratland, et al.. (2021). Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 study): an open-label, nonrandomized, multicenter, phase II trial. Annals of Oncology. 32(10). 1276–1285. 125 indexed citations
8.
Ghazawi, Feras M., Michelle Le, François Lagacé, et al.. (2019). Incidence, Mortality, and Spatiotemporal Distribution of Cutaneous Malignant Melanoma Cases Across Canada. Journal of Cutaneous Medicine and Surgery. 23(4). 394–412. 36 indexed citations
9.
Tsang, Matthew, Michelle Le, Feras M. Ghazawi, et al.. (2019). Multiple myeloma epidemiology and patient geographic distribution in Canada: A population study. Cancer. 125(14). 2435–2444. 36 indexed citations
10.
11.
Bayoumi, Nader, et al.. (2019). Ultrasound Biomicroscopy for Evaluation of Skin of the Temporal Region in Obese Middle Aged Females. 6(3). 1 indexed citations
12.
Le, Maithao, Feras M. Ghazawi, Elena Netchiporouk, et al.. (2019). Incidence and Mortality Trends and Geographic Patterns of Follicular Lymphoma in Canada. Current Oncology. 26(4). 473–481. 20 indexed citations
13.
Le, Maithao, Feras M. Ghazawi, Elham Rahme, et al.. (2019). Prevalence of Human T Cell Lymphotropic Virus 1 Infection in Canada. Current Oncology. 26(1). 3–5. 16 indexed citations
14.
Muntyanu, Anastasiya, Margaret Redpath, Osama Roshdy, & Abdulhadi Jfri. (2018). Idiopathic Atrophoderma of Pasini and Pierini: Case report and literature review. Clinical Case Reports. 7(2). 258–263. 7 indexed citations
15.
Ghazawi, Feras M., Rami Darwich, Michelle Le, et al.. (2018). Cutaneous malignant melanoma incidence and mortality trends in Canada: A comprehensive population-based study. Journal of the American Academy of Dermatology. 80(2). 448–459. 58 indexed citations
16.
Ghazawi, Feras M., Elena Netchiporouk, Elham Rahme, et al.. (2017). Distribution and Clustering of Cutaneous T-Cell Lymphoma (CTCL) Cases in Canada During 1992 to 2010. Journal of Cutaneous Medicine and Surgery. 22(2). 154–165. 43 indexed citations
17.
Saxena, Anjali, et al.. (2015). Iatrogenic Kaposi's sarcoma after immunosuppressive treatment for granulomatosis with polyangiitis (Wegener's). JAAD Case Reports. 1(2). 71–73. 10 indexed citations
18.
Netchiporouk, Elena, et al.. (2015). Hypopigmented Segmental Darier Disease. Journal of Cutaneous Medicine and Surgery. 19(1). 69–72. 3 indexed citations
19.
Roshdy, Osama, et al.. (2010). Hook-Shaped Needle-Guided Shave Biopsy: A Modified Technique Applied to Difficult Anatomic Locations. Dermatologic Surgery. 36(12). 2045–2046.
20.
Roshdy, Osama, et al.. (1999). Risk profiles for sexually transmitted diseases among patients attending the venereal disease clinic at Alexandria Main University Hospital. Eastern Mediterranean Health Journal. 5(4). 740–754. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ausilia Maria Manganoni Breakdown of academic impact, for papers by V. Buffard Breakdown of academic impact, for papers by Ariënne M. W. Van Marion Breakdown of academic impact, for papers by Anne-Bénédicte Duval-Modeste Breakdown of academic impact, for papers by Matthew Tsang Breakdown of academic impact, for papers by Silvana Festa Breakdown of academic impact, for papers by Anna Peroni Breakdown of academic impact, for papers by Marit Scheistrøen Breakdown of academic impact, for papers by Nina Booken Breakdown of academic impact, for papers by Karl Rodins
Rankless by CCL
2026